Target intelligence / Profile preview

Oral pathogenic mixed-species biofilm

Molecular classification
Microbial community, Extracellular polymeric substance (EPS) matrix
01

Overview

Oral pathogenic mixed-species biofilms are complex, highly organized microbial communities composed of bacteria, fungi, and viruses embedded within a self-produced matrix of extracellular polymeric substances (EPS) [1][3]. These biofilms adhere to various oral surfaces, including tooth enamel, gingival tissues, and prosthetic implants, where they facilitate metabolic cooperation and provide a protective environment against host immune defenses and exogenous antimicrobial agents [2][4]. While the oral microbiome typically exists in a symbiotic state, environmental shifts can trigger dysbiosis, leading to the overgrowth of pathogenic species such as Streptococcus mutans or Porphyromonas gingivalis [1][4]. This transition is a primary driver of prevalent oral diseases, including dental caries and periodontitis, which can have systemic health implications [2]. Therapeutic interventions aim to manage these biofilms through mechanical disruption, chemical degradation of the EPS matrix, or the application of broad-spectrum and targeted antimicrobials [1][3]. Effective management requires balancing the reduction of pathogenic load with the preservation of the beneficial commensal microflora to maintain oral homeostasis [4].

Other names
Dental plaqueOral biofilmPolymicrobial oral biofilmSubgingival biofilmSupragingival biofilm
02

Mechanism of action

Disruption of the extracellular polymeric substance (EPS) matrix, inhibition of bacterial adhesion to oral surfaces, interference with quorum sensing signaling, and direct bactericidal or bacteriostatic activity against constituent pathogenic species.

03

Biological functions

Quorum sensingMetabolic cross-feedingAntimicrobial resistanceNiche colonizationAdhesion
04

Disease associations

Dental cariesPeriodontitisGingivitisPeri-implantitisEndodontic infection
05

Safety considerations

Oral dysbiosis (disruption of commensal flora)Development of antimicrobial resistanceTooth and tongue stainingMucosal irritationAlteration of taste perception
06

Interacting drugs

Chlorhexidine

7 more in the full profile.

07

Biomarkers

Plaque Index (PI)Gingival Index (GI)Colony Forming Units (CFU) of Porphyromonas gingivalisColony Forming Units (CFU) of Streptococcus mutansExtracellular Polymeric Substance (EPS) concentration

Beyond the preview

Go deeper on Oral pathogenic mixed-species biofilm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral pathogenic mixed-species biofilm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call